Invivyd, Inc. (NASDAQ:IVVD) Q2 2023 Earnings Call Transcript

Invivyd, Inc. (NASDAQ:IVVD) Q2 2023 Earnings Call Transcript August 12, 2023 Operator: Welcome to the Invivyd Second Quarter 2023 Business and Financial Results Update Call. I will now turn the call over to Gabriella Linville-Engler, Director of External Communications. Gabriella Linville-Engler: Thank you for joining us today. Before we get started, I want to tend […]

Related Keywords

Pressmaster Shutterstock ,Pete Schmidt ,Dave Hering ,Vaccines Advisory Committee ,Most Instagram Users ,Phase 1 Clinical Trial ,Immunocompromised ,Invivyd ,Nc ,Clinical Trial ,Covid ,Primary Endpoint ,